Prodrax

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameProdrax
Drug Alias Namechloroethylamino-anthraquinone di-N-oxide prodrug (Access Pharmaceuticals)chloroethylamino-anthraquinone di-N-oxide prodrug (Somanta)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBioreducible cytotoxinCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSomanta Pharmaceuticals IncAbeona Therapeutics IncUniversity Of London
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A